Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2026-04-19 @ 12:06 AM
Study NCT ID:
NCT06781450
Status:
RECRUITING
Last Update Posted:
2025-01-30
First Post:
2024-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context
Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PRIMICI
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None